1387 related articles for article (PubMed ID: 7018190)
1. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
3. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
4. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
5. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
Overlack A; Stumpe KO; Heck I; Krück F
Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
[TBL] [Abstract][Full Text] [Related]
6. Captopril, aldosterone and urinary kallikrein in primary hypertension.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Clin Exp Hypertens A; 1983; 5(4):523-9. PubMed ID: 6342863
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
9. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
Wong PY; Talamo RC; Williams GH; Colman RW
J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
[TBL] [Abstract][Full Text] [Related]
10. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
11. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
12. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
13. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
[TBL] [Abstract][Full Text] [Related]
14. [Captopril in the treatment of essential hypertension (author's transl)].
Lederle RM; Klaus D; Braun B
Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
[TBL] [Abstract][Full Text] [Related]
15. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
Iimura O; Shimamoto K
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
[TBL] [Abstract][Full Text] [Related]
16. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
17. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
[TBL] [Abstract][Full Text] [Related]
19. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
[TBL] [Abstract][Full Text] [Related]
20. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
